Bell Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$916 Hold
108
– – ﹤0.01% 1551
2026
Q1
$589 Buy
108
+94
+671% +$527 ﹤0.01% 1688
2025
Q4
$98 Sell
14
-88
-86% -$689 ﹤0.01% 1793
2025
Q3
$789 Hold
102
– – ﹤0.01% 1624
2025
Q2
$889 Buy
102
+84
+467% +$609 ﹤0.01% 1622
2025
Q1
$144 Hold
18
– – ﹤0.01% 1881
2024
Q4
$164 Hold
18
– – ﹤0.01% 1879
2024
Q3
$166 Sell
18
-37
-67% -$306 ﹤0.01% 1862
2024
Q2
$538 Buy
55
+4
+8% +$49 ﹤0.01% 1791
2024
Q1
$771 Buy
51
+33
+183% +$599 ﹤0.01% 1675
2023
Q4
$388 Hold
18
– – ﹤0.01% 1871
2023
Q3
$335 Sell
18
-21
-54% -$490 ﹤0.01% 1884
2023
Q2
$988 Hold
39
– – ﹤0.01% 1609
2023
Q1
$1.01K Sell
39
-53
-58% -$1.42K ﹤0.01% 1568
2022
Q4
$2.18K Buy
92
+60
+188% +$1.62K ﹤0.01% 1246
2022
Q3
$1K Sell
32
-17
-35% -$596 ﹤0.01% 1589
2022
Q2
$2K Buy
+49
New +$2.08K ﹤0.01% 1242
2021
Q4
$3K Sell
32
-44
-58% -$5.26K ﹤0.01% 1038
2021
Q3
$10K Buy
+76
New +$11.1K ﹤0.01% 464

Other funds holding TDOC

Bell Investment Advisors's TDOC Position: Q2 2026 in Review

Bell Investment Advisors held its Teladoc Health (TDOC) position steady in Q2 2026 at 108 shares worth $916. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Bell Investment Advisors first reported a position in TDOC in Q3 2021 and has held it in 19 quarters since. The position peaked at $10K in Q3 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Bell Investment Advisors held 108 shares of Teladoc Health worth $916 as of Q2 2026.
  • Bell Investment Advisors left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1551 holding.
  • Bell Investment Advisors first reported a position in Teladoc Health in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Teladoc Health position peaked at $10K in Q3 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.